Benjamin Seeliger, Hannover, Germany, spoke to us at ERS 2019 in Madrid about the EOLIA trial and ECMO in veno-venous extracorporeal membrane oxygenation therapy.
Questions
1. What is known about the effectiveness of extracorporeal membrane oxygenation (ECMO) in respiratory failure? (0:05)
2. What are the major challenges in designing clinical trials to investigate the utility of ECMO in this clinical setting? (0:30)
3. Could you tell us a little about the EOLIA trial and its findings? (1:17)
4. What were the limitations of this study? (2:59)
5. What will be the impact of this study on clinical practice and what future research is needed? (4:10)
Speaker disclosures: Benjamin Seeliger has received a travel grant from Chiesi GmbH (Germany).
touchRESPIRATORY.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.
Filmed at the European Respiratory Society (ERS) International Congress 2019, Madrid, Spain.
